1. Home
  2. TRVG vs ENTA Comparison

TRVG vs ENTA Comparison

Compare TRVG & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo trivago N.V.

TRVG

trivago N.V.

HOLD

Current Price

$6.59

Market Cap

422.6M

Sector

Technology

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$12.22

Market Cap

377.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRVG
ENTA
Founded
2005
1995
Country
Germany
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
422.6M
377.5M
IPO Year
2015
2012

Fundamental Metrics

Financial Performance
Metric
TRVG
ENTA
Price
$6.59
$12.22
Analyst Decision
Hold
Strong Buy
Analyst Count
6
5
Target Price
$3.95
$20.40
AVG Volume (30 Days)
187.7K
231.6K
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.93
EPS
N/A
N/A
Revenue
N/A
$102,814,000.00
Revenue This Year
$15.59
$7.76
Revenue Next Year
$8.42
N/A
P/E Ratio
$16.98
N/A
Revenue Growth
N/A
16.48
52 Week Low
$2.59
$7.05
52 Week High
$6.80
$17.15

Technical Indicators

Market Signals
Indicator
TRVG
ENTA
Relative Strength Index (RSI) 63.77 40.47
Support Level $2.76 $12.19
Resistance Level N/A $14.03
Average True Range (ATR) 0.54 0.54
MACD 0.06 -0.14
Stochastic Oscillator 81.65 10.33

Price Performance

Historical Comparison
TRVG
ENTA

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments, namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and all other countries.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: